Interpretation
of Tests Results - 1
9 Reduced levels of complement components
E complement
consumption during in vivo formation of ag-ab complexes
E reduced
synthesis of complement
E increased
catabolism of complement
E presence of
an inhibitor to complement
9 Reduced levels of complement activity
E seen in diseases such as:
U lymphoma
U allograft
rejection
U infectious
hepatitis with arthritis
U severe
combined immunodeficiency
U Systemic
lupus with glomerularnephritis
U immune
complex disease
